Cornerstone Investment Partners, LLC Catalyst Pharmaceuticals, Inc. Transaction History

Cornerstone Investment Partners, LLC

  • $1.91 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Jul 29, 2022
SELL
$6.23 - $8.57 $142,822 - $196,467
-22,925 Closed
0 $0
Q1 2022

Apr 29, 2022
BUY
$5.31 - $8.31 $121,731 - $190,506
22,925 New
22,925 $190,000
Q1 2021

Apr 26, 2021
SELL
$3.45 - $4.69 $160,821 - $218,624
-46,615 Closed
0 $0
Q4 2020

Jan 28, 2021
BUY
$2.97 - $3.83 $138,446 - $178,535
46,615 New
46,615 $156,000

Others Institutions Holding CPRX

# of Institutions
326
Shares Held
94.6M
Call Options Held
19.1K
Put Options Held
51.1K
View Full List

About CATALYST PHARMACEUTICALS, INC.

CPRX Quotes by TradingView
  • Ticker CPRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 102,820,000
  • Market Cap $2.12B
  • Description
  • Catalyst Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies for people with rare debilitating, chronic neuromuscular, and neurological diseases in the United States. It offers Firdapse, an amifampridine phosphate tablets for the treatment of patients with lambert-eaton myasthe...
More about CPRX
Track This Portfolio

Track Cornerstone Investment Partners, LLC Portfolio

Follow Cornerstone Investment Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cornerstone Investment Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cornerstone Investment Partners, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email